On the occasion of the World Osteoporosis Day which takes place every year on October 20th, Gnosis has participated at the special event “Supplements in the non-pharmacologic treatment of osteoporosis” with a speech held by Dr. Luca Tiano – presenting new highlights and evidence of the use of vitamin K2 menaquinone-7 in the form of vitaMK7® and K2&Olive™. Researcher in Biochemistry, Dr Luca Tiano actually works in the Department of Odontostomatologic and Specialized Clinical Sciences at the Polytechnic University of Marche (Ancona –Italy).
This vitamin has attracted most of the attention of the audience, made up of medical doctors and scientists, flocked at the conference to be updated on new and effective nutrients in bone health.
Dr. Tiano has described the role of vitamin K2 the in the form of menaquinone-7 in bone metabolism, according to what the scientific research has elucidated in the last years, showing as it may help in reducing the risk of osteoporotic fractures and could be considered a good nutrient for the prevention of osteoporosis.
Since 1996, the World Osteoporosis Day launches a year-long campaign dedicated to raising global awareness of the prevention, diagnosis and treatment of osteoporosis and metabolic bone disease. Organized by the International Osteoporosis Foundation (IOF), World Osteoporosis Day involves campaigns by national osteoporosis patient societies from around the world with activities in over 90 countries. For more information contact marketing@gnosis-bio.com.
In particular he highlighted the benefits of vitaMK7®, the natural Vitamin K2 obtained through a patented biofermentation process of Bacillus subtilis spp natto
